| 标题 |
Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hematology 作者:Wen-Jing Yu; Jun Kong; Feng-Mei Zheng; Xiao-Dong Mo; Xiao-Hui Zhang; et al 出版日期:2024-11-12 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)